These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 15239234)

  • 1. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of p53 protein overexpression and DNA ploidy analysis in colon cancer.
    Attallah AM; Elhak NG; Nasif WA; Tabll A; Ezzat F
    Hepatogastroenterology; 1997; 44(18):1595-601. PubMed ID: 9427029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 expression and DNA ploidy pattern in Egyptian colorectal carcinoma.
    Zalata KR; Leech SH; Ming SC; Nasif WA; Nada NA; Mohamed IE; Atallah AM; Gad-el-Hak NA
    Hepatogastroenterology; 2002; 49(47):1225-9. PubMed ID: 12239910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy.
    Nakopoulou L; Constantinides C; Papandropoulos J; Theodoropoulos G; Tzonou A; Giannopoulos A; Zervas A; Dimopoulos C
    Urology; 1995 Sep; 46(3):334-40. PubMed ID: 7660508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
    Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon cancer: p53 expression and DNA ploidy. Their relation to proximal or distal tumor site.
    García-Hirschfeld García J; Blanes Berenguel A; Vicioso Recio L; Márquez Moreno A; Rubio Garrido J; Matilla Vicente A
    Rev Esp Enferm Dig; 1999 Jul; 91(7):481-8. PubMed ID: 10477366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas.
    Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K
    J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An immunohistochemical study of the relationship between p53 expression and the DNA ploidy pattern using image cytometry in colorectal carcinoma].
    Miki T; Funahashi K; Tsujita K; Takatsuki M; Koike J; Kubota S; Goto T; Nagasawa Y; Kobayashi K; Yanagita K
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():130-3. PubMed ID: 7611775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
    Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
    Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
    Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
    Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between DNA content and p53 deletion in colorectal cancer.
    Cianchi F; Balzi M; Becciolini A; Giachè V; Messerini L; Palomba A; Tisti E; Faraoni P; Chellini F; Pucciani F; Perigli G; Cortesini C
    Eur J Surg; 1999 Apr; 165(4):363-8. PubMed ID: 10365839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [DNA ploidy pattern and p53 overexpression in gastric cancer].
    Tomisaki S; Tatsuo O; Hisao O; Sakaguchi Y; Kusumoto T; Ohno S; Ichiyoshi Y; Maehara Y; Sugimachi K
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():115-7. PubMed ID: 7611772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
    Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of p53 expression and DNA ploidy pattern in esophageal cancer].
    Naitoh H; Kawaguchi A; Shibata J; Umeda T; Kodama M; Hattori T
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():110-4. PubMed ID: 7611771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Flow cytometric measurement of p53 protein and DNA content in colorectal carcinomas with liver metastasis].
    Kimura O; Hisamitsu K; Sugamura K; Nakamura S; Kurayoshi K; Makino M; Kaibara N
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():134-9. PubMed ID: 7611776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.